Visual inspection with acetic acid (VIA) positivity among female sex workers: a cross-sectional study highlighting one-year experiences in early detection of pre-cancerous and cancerous cervical lesions in Kampala, Uganda.

Female sex workers (FSWs) HIV cervical intra-epithelial neoplasia (CIN) screening visual inspection with acetic acid (VIA)

Journal

Infectious agents and cancer
ISSN: 1750-9378
Titre abrégé: Infect Agent Cancer
Pays: England
ID NLM: 101276559

Informations de publication

Date de publication:
11 May 2021
Historique:
received: 23 02 2021
accepted: 01 05 2021
entrez: 12 5 2021
pubmed: 13 5 2021
medline: 13 5 2021
Statut: epublish

Résumé

Although cervical cancer is preventable, most women in sub-Saharan Africa (SSA) do not receive routine screening and few treatment options exist. Female Sex Workers (FSWs) are among the Ugandan female population at highest risk of acquiring sexually transmitted infections (STIs) including HIV and human papilloma viruses (HPV), the cause of cervical cancer. We report one-year experiences of visual inspection with acetic acid (VIA) positivity among FSWs in the early detection of pre-cancerous and cancerous cervical lesions in Kampala, Uganda. Between June 2014 and July 2015, we enrolled FSWs into a cross-sectional study at a research clinic. The women were screened using the VIA method (application of 3-5 % acetic acid to the cervix). All VIA positive women were referred to a tertiary hospital for colposcopy, biopsy, and immediate treatment (if indicated) at the same visit according to national guidelines. Data on socio-demographic, sexual behaviour, sexual reproductive health and clinical characteristics were collected. We used logistic regression to identify factors associated with VIA positivity. Of 842 women assessed for eligibility, 719 (85 %) of median age 30 (IQR 26, 35) were screened, and 40 (6 %) women were VIA positive. Of the 24 histology specimens analysed, 6 showed inflammation, only 1 showed cervical intraepithelial neoplasia (CIN) 1, 13 women showed CIN2/3, while 4 women already had invasive cervical cancer. The overall prevalence of HIV was 43 %, of whom only 35 % were receiving ART. In the age-adjusted analysis, VIA positivity was more likely among women who reported having > 100 life-time partners (aOR = 3.34, 95 %CI: 1.38-8.12), and HIV positive women (aOR = 4.55; 95 %CI: 2.12-9.84). We found a relatively low proportion of VIA positivity in this population. The experience from our program implies that the VIA results are poorly reproducible even among a category of trained professional health workers. VIA positivity was more likely among women with a high number of sexual partners and HIV infection. Interventions for improving cervical cancer screening should be recommended as part of HIV care for FSWs to reduce the disease burden in this population.

Sections du résumé

BACKGROUND BACKGROUND
Although cervical cancer is preventable, most women in sub-Saharan Africa (SSA) do not receive routine screening and few treatment options exist. Female Sex Workers (FSWs) are among the Ugandan female population at highest risk of acquiring sexually transmitted infections (STIs) including HIV and human papilloma viruses (HPV), the cause of cervical cancer. We report one-year experiences of visual inspection with acetic acid (VIA) positivity among FSWs in the early detection of pre-cancerous and cancerous cervical lesions in Kampala, Uganda.
METHODS METHODS
Between June 2014 and July 2015, we enrolled FSWs into a cross-sectional study at a research clinic. The women were screened using the VIA method (application of 3-5 % acetic acid to the cervix). All VIA positive women were referred to a tertiary hospital for colposcopy, biopsy, and immediate treatment (if indicated) at the same visit according to national guidelines. Data on socio-demographic, sexual behaviour, sexual reproductive health and clinical characteristics were collected. We used logistic regression to identify factors associated with VIA positivity.
RESULTS RESULTS
Of 842 women assessed for eligibility, 719 (85 %) of median age 30 (IQR 26, 35) were screened, and 40 (6 %) women were VIA positive. Of the 24 histology specimens analysed, 6 showed inflammation, only 1 showed cervical intraepithelial neoplasia (CIN) 1, 13 women showed CIN2/3, while 4 women already had invasive cervical cancer. The overall prevalence of HIV was 43 %, of whom only 35 % were receiving ART. In the age-adjusted analysis, VIA positivity was more likely among women who reported having > 100 life-time partners (aOR = 3.34, 95 %CI: 1.38-8.12), and HIV positive women (aOR = 4.55; 95 %CI: 2.12-9.84).
CONCLUSIONS CONCLUSIONS
We found a relatively low proportion of VIA positivity in this population. The experience from our program implies that the VIA results are poorly reproducible even among a category of trained professional health workers. VIA positivity was more likely among women with a high number of sexual partners and HIV infection. Interventions for improving cervical cancer screening should be recommended as part of HIV care for FSWs to reduce the disease burden in this population.

Identifiants

pubmed: 33975633
doi: 10.1186/s13027-021-00373-4
pii: 10.1186/s13027-021-00373-4
pmc: PMC8114699
doi:

Types de publication

Journal Article

Langues

eng

Pagination

31

Références

BMC Infect Dis. 2011 Dec 02;11:333
pubmed: 22136570
Malawi Med J. 2018 Sep;30(3):211-214
pubmed: 30627358
Sex Transm Dis. 2011 Apr;38(4):316-23
pubmed: 23330152
J Low Genit Tract Dis. 2016 Jan;20(1):31-7
pubmed: 26579842
Curr Opin Obstet Gynecol. 2016 Feb;28(1):4-10
pubmed: 26642063
Int J Cancer. 2008 Jul 1;123(1):153-60
pubmed: 18404671
Gynecol Oncol Rep. 2017 Jan 29;20:18-21
pubmed: 28224134
Reprod Health Matters. 2008 Nov;16(32):67-77
pubmed: 19027624
Ann Oncol. 2011 Dec;22(12):2675-2686
pubmed: 21471563
Histopathology. 2002 Apr;40(4):377-90
pubmed: 11943024
BMC Int Health Hum Rights. 2017 May 5;17(1):11
pubmed: 28476153
Prim Health Care Res Dev. 2019 Jul 01;20:e93
pubmed: 32799996
Cult Health Sex. 2004 May;6(3):239-54
pubmed: 21972876
BMC Public Health. 2013 Aug 10;13:741
pubmed: 23938037
Int J Cancer. 2014 Jul 15;135(2):432-9
pubmed: 24615279
Int J Gynaecol Obstet. 2015 Oct;131 Suppl 1:S28-32
pubmed: 26433500
Open AIDS J. 2013 Dec 30;7:58-66
pubmed: 24511334
Int J Gynecol Cancer. 2013 Mar;23(3):507-12
pubmed: 23354369
Asian Pac J Cancer Prev. 2013;14(12):7761-2
pubmed: 24460365
Int J Womens Health. 2015 May 04;7:477-83
pubmed: 25999765
Int J Cancer. 2010 Dec 15;127(12):2893-917
pubmed: 21351269
Infect Agent Cancer. 2011 Jun 25;6(1):8
pubmed: 21702999
BMC Infect Dis. 2010 Jan 26;10:18
pubmed: 20102630
BMC Infect Dis. 2012 Jul 28;12:166
pubmed: 22839728
BMC Public Health. 2012 Mar 23;12:237
pubmed: 22443255
J Int AIDS Soc. 2012 Jun 18;15(2):17406
pubmed: 22713260
Indian J Community Med. 2015 Jul-Sep;40(3):203-7
pubmed: 26170547
BMJ. 2015 Jul 03;351:h3084
pubmed: 26142020
J Med Virol. 2006 Jul;78(7):950-3
pubmed: 16721861
Reprod Health. 2010 May 10;7:4
pubmed: 20459733

Auteurs

Gertrude Namale (G)

MRC/UVRI and LSHTM Uganda Research Unit, P.O Box 49, Entebbe, Uganda. gertrude.namale@mrcuganda.org.

Yunia Mayanja (Y)

MRC/UVRI and LSHTM Uganda Research Unit, P.O Box 49, Entebbe, Uganda.

Onesmus Kamacooko (O)

MRC/UVRI and LSHTM Uganda Research Unit, P.O Box 49, Entebbe, Uganda.

Daniel Bagiire (D)

MRC/UVRI and LSHTM Uganda Research Unit, P.O Box 49, Entebbe, Uganda.

Agnes Ssali (A)

MRC/UVRI and LSHTM Uganda Research Unit, P.O Box 49, Entebbe, Uganda.

Janet Seeley (J)

MRC/UVRI and LSHTM Uganda Research Unit, P.O Box 49, Entebbe, Uganda.
London School of Hygiene &Tropical Medicine, London, United Kingdom.

Robert Newton (R)

MRC/UVRI and LSHTM Uganda Research Unit, P.O Box 49, Entebbe, Uganda.
University of York, York, United Kingdom.

Anatoli Kamali (A)

MRC/UVRI and LSHTM Uganda Research Unit, P.O Box 49, Entebbe, Uganda.

Classifications MeSH